0001628280-21-020527.txt : 20211026
0001628280-21-020527.hdr.sgml : 20211026
20211026163324
ACCESSION NUMBER: 0001628280-21-020527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211025
FILED AS OF DATE: 20211026
DATE AS OF CHANGE: 20211026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huizinga Robert Bindert
CENTRAL INDEX KEY: 0001837648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 211349016
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: BC V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_163528039067523.xml
FORM 4
X0306
4
2021-10-25
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001837648
Huizinga Robert Bindert
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
0
1
0
0
EVP of Research
Common Stock
2021-10-25
4
M
0
95000
3.20
A
195728
D
Common Stock
2021-10-25
4
S
0
130000
29.75
D
65728
D
Stock Option (right to buy)
3.2
2021-10-25
4
M
0
95000
0
D
2027-02-09
Common Stock
95000.0
3864
D
Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $29.50 to $30.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date.
/s/ Robert Bindert Huizinga
2021-10-26